LTFS
WVE icon

Ladenburg Thalmann Financial Services’s Wave Life Sciences WVE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-220
Closed -$6K – 4981
2016
Q4 		$6K Hold
220
– – ﹤0.01% 4157
2016
Q3 		$7K Buy
+220
New +$5.2K ﹤0.01% 4030

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Ladenburg Thalmann Financial Services's WVE Position: Q1 2017 in Review

Ladenburg Thalmann Financial Services sold out of Wave Life Sciences (WVE) in Q1 2017, closing a stake of 220 shares — an estimated $6K sold.

Ladenburg Thalmann Financial Services first reported a position in WVE in Q3 2016 and held it in 2 quarters. The position peaked at $7K in Q3 2016. 49 funds tracked by Wall St. Rank hold WVE as of Q1 2017.

  • Ladenburg Thalmann Financial Services reported no remaining Wave Life Sciences position as of Q1 2017 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 220 Wave Life Sciences shares in Q1 2017, an estimated $6K.
  • Ladenburg Thalmann Financial Services first reported a position in Wave Life Sciences in Q3 2016 and held it in 2 quarters.
  • Ladenburg Thalmann Financial Services's Wave Life Sciences position peaked at $7K in Q3 2016.
  • 49 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2017, filed 15 May 2017.